News

Penthrox is recommended for use in all UK ambulances

Medical Developments International Ltd (ASX: MVP) is delighted to advise the Joint Royal Colleges Ambulance Liaison Committee (JRCALC) has issued its new pain management clinical practice guidelines for UK ambulance services teams. The JRCALC guidelines now recommend the…

Sienna Diagnostics: Exclusive Distributor Appointed for Denmark and Sweden

Melbourne, Australia, 25 September 2017: Sienna Cancer Diagnostics, a commercial stage, medical technology company focussed on the development and commercialisation of innovative cancer-related tests, is pleased to announce the appointment of Axlab A/S as its exclusive distribution partner…

Starpharma – DEP® docetaxel positive phase 1 results; phase 2 commences

DEP® docetaxel phase 1 trial successfully completed with phase 2 to commence immediately DEP® docetaxel patients had no reports of neutropenia, a life-threatening toxicity seen in virtually all patients treated with conventional docetaxel formulations (e.g. Taxotere®)   Encouraging signs of efficacy observed…

5th October – BioWorkshop – Global Pathways to Pre-Clinical Development Success

Learn approaches on how to design your pre-clinical studies from the experts! This workshop will cover global technical and regulatory strategies for pre-clinical development of medicines, from small molecules and biologics, to cell and gene therapies. Attendees will…

Speaking Opportunities: Devices + Diagnostics Lab March 2018 – Disruptive Diagnostics

We’re starting to work on the Program for the 2018 Devices + Diagnostics Lab which will take place on Tuesday 27th March next year. If you have any suggestions for speakers, topics or technologies that you would like…

Ask Industry Anything (Again) – Tuesday 28th November 2017

BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…

BTF – Medical technology investment to improve lives

The Turnbull Government will fund three medical breakthroughs to help people with severe disabilities walk again and support thousands of Australians facing crippling chronic back pain.A total of $13.3 million will be invested into high potential Australian innovations…

Victorian patients with frontotemporal dementia to trial new drug

IN a world-first trial, Victorians with a devastating form of dementia that strikes in middle age will be given a drug aimed at slowing the disease. Thousands of Australians have the condition, which causes changes in personality and…

Discovery Award to support new test for sepsis

Burnet Institute’s Global Health Diagnostics Laboratory has been awarded a prestigious Longitude Prize Discovery Award to facilitate the development of a laboratory-based sepsis assay into a point-of-care test. The award will also support the Laboratory’s bid for a…

BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017

With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…

Attention all Victorians attending AusBiotech 2017 in Adelaide

The Victorian Government will be hosting a stand in the Exhibition Hall for the duration of the AusBiotech Conference, promoting Victoria as a leading global location for biotechnology. You are encouraged to drop by the stand to connect…

Hydrix & Panorama

Today it was announced that Panorama Synergy Limited (ASX: PSY) has entered into an agreement to fully acquire Hydrix through an asset purchase agreement. This is an exciting development for both companies with the Merged Group at the…

Home

News & opinion

Member Directory

Events